Abstract
Alpha-synuclein seed amplification assays can improve neurodegenerative disease diagnosis and care, but widespread use depends on a framework that standardizes protocols and encourages data sharing.
MeSH terms
-
Humans
-
Information Dissemination*
-
Neurodegenerative Diseases* / diagnosis
-
Neurodegenerative Diseases* / genetics
-
Neurodegenerative Diseases* / metabolism
-
Nucleic Acid Amplification Techniques* / methods
-
Nucleic Acid Amplification Techniques* / standards
-
alpha-Synuclein* / genetics
-
alpha-Synuclein* / metabolism